Harm Reduction

Harm reduction refers to a set of strategies that reduce the harms associated with substance use. By meeting people where they are, harm reduction providers build trust with people who use drugs (PWUD), equipping them with the tools and information to protect themselves from infectious diseases and overdose.

Syringe services programs (SSPs) are an effective, safe, and cost-saving strategy to prevent the spread of HIV and viral hepatitis. Comprehensive SSPs offer syringe distribution and disposal, conduct education and counseling, and provide or refer clients to HIV, STI, hepatitis, and substance use disorder services. They may also distribute the overdose reversal medication naloxone, fentanyl test strips, condoms, or other supplies to prevent infectious diseases or overdose.

Local health departments (LHDs) play a critical role in providing and supporting harm reduction services. NACCHO supports LHDs by increasing buy-in, facilitating peer learning and engagement, and providing technical and capacity building assistance for harm reduction programs.

The work of local health departments (LHDs) has been severely impacted since the onset of the COVID-19 pandemic. Much of their staff has been activated as part of an emergency response to combat the virus, and many of their day-to-day activities have been suspended or are operating at a reduced capacity. Read more about the impact of COVID-19 on HIV, STI, viral hepatitis, and overdose response activities at at LHDs in our below Reports from the Field.

In the wake of the 2015 HIV outbreak in Scott County, Indiana – and in response to the Centers for Disease Control and Prevention’s (CDC’s) vulnerability assessment, which identified 220 counties most vulnerable to an outbreak of hepatitis C and HIV among PWID – the LENOWISCO Health District of the Virginia Department of Health initiated efforts to develop a comprehensive community response plan to address this vulnerability. The District, made up of four localities in rural southwest Virginia - Lee, Norton, Wise, and Scott - has been heavily impacted by the opioid epidemic and two of its counties were identified in the CDC’s assessment.

Read Community Response Planning for Outbreaks of Hepatitis and HIV Among People Who Inject Drugs: A Case Study from the LENOWISCO Health District, a Rural Community in Virginia to learn about the process the health department took for developing the Community Response Plan, lessons learned, and next steps for putting the plan into action. The full document is 138 pages, but each component can be individually accessed below:

Recent News

  • HIV, STI, & Viral Hepatitis STI/HIV Program Director Continuing Education Program

STI/HIV Program Directors Leadership Development

Check out this formative assessment carried out by NACCHO, CDC< and Cardea...

Nov 04, 2024

STI/HIV Program Directors Leadership Development

  • Tools & Resources Financing & Economics HIV, STI, & Viral Hepatitis Policy

Medicare Part B Coverage of Pre-exposure Prophylaxis...

Medicare will begin covering HIV PrEP without cost-sharing. Learn what that...

Oct 01, 2024 | Julia Zigman

Medicare Part B Coverage of Pre-exposure Prophylaxis...

SNAP ETAP Full Color 1
  • HIV, STI, & Viral Hepatitis

SNAP ETAP at NACCHO360 and the National Ryan White...

Whole-person approaches to HIV prevention/care emphasize comprehensive, quality...

Sep 30, 2024 | JSI Research & Training Institute, Inc

SNAP ETAP at NACCHO360 and the National Ryan White...

SNAP ETAP 600x400 tsp
  • HIV, STI, & Viral Hepatitis

Introducing the SNAP ETAP Initiative

Whole-person approaches to HIV prevention/care emphasize comprehensive, quality...

Sep 30, 2024 | JSI Research & Training Institute, Inc

Introducing the SNAP ETAP Initiative

  • HIV, STI, & Viral Hepatitis HIV, STI, Viral Hepatitis, and Harm Reduction Digest

Digest (July 17, 2024)

HIV, STI, Viral Hepatitis, and Harm Reduction Digest: July 17, 2024

Jul 17, 2024

Digest (July 17, 2024)

  • HIV, STI, & Viral Hepatitis

NACCHO Applauds FDA Approval of First Point-of-Care RNA...

On June 27, the US Food and Drug Administration (FDA) approved the first-ever...

Jul 16, 2024 | Kat Kelley

NACCHO Applauds FDA Approval of First Point-of-Care RNA...

  • HIV, STI, & Viral Hepatitis

Happy National HIV Testing Day!

Today is a day to encourage HIV testing, knowing your status, and continuing to...

Jun 27, 2024

Happy National HIV Testing Day!

  • HIV, STI, & Viral Hepatitis

New NACCHO Resource: Chlamydia and Gonorrhea...

This toolkit aims to assist community pharmacists across the country with...

May 07, 2024

New NACCHO Resource: Chlamydia and Gonorrhea...

  • HIV, STI, & Viral Hepatitis

Request for Proposals: Capacity-Building/Training...

NACCHO is working with the CDC DSTDP to build the capacity of STD public health...

May 01, 2024

Request for Proposals: Capacity-Building/Training...

Webinar Title Description Slides Date Additional Resources
Smoking Supplies Webinar The distribution of smoking supplies has emerged as a promising harm reduction strategy to engage people who use drugs, reduce overdoses, and prevent infectious diseases. In March 2023, NACCHO conducted a survey to better understand the implementation of smoking supplies, including the impact and benefits, factors that support this work, and barriers that undermine it. On July 31st, NACCHO shared the results of the survey and two organizations, The Phoenix Center and Public Health Madison Dane County, shared their experience with implementing smoking supplies. Slides July 31, 2023 Blog post with additional resources
I Stock 1461189407

Harm Reduction Community of Practice

NACCHO launched the Harm Reduction Community of Practice (CoP) to increase the...

Feb 01, 2023

Harm Reduction Community of Practice

I Stock 1405279677

Harm Reduction Listserv

To support our growing harm reduction portfolio, NACCHO is launching a new...

Feb 01, 2023

Harm Reduction Listserv

For questions about NACCHO's work regarding harm reduction, contact our harm reduction specialists below.

Community Health Program

Julie Karr

Senior Program Analyst, Harm Reduction

JavaScript is required to reveal this message. / Email

Community Health Program

Anjana Rao

Program Analyst, Harm Reduction

JavaScript is required to reveal this message. / Email

Community Health Program

Kat Kelley

Lead Analyst – Syndemics - HIV, STIs, Viral Hepatitis, & Harm Reduction

JavaScript is required to reveal this message. / Email

Communications

Grace Murtha

Communications Specialist

JavaScript is required to reveal this message. / Email

Community Health Program

Randy May

Director, HIV & Harm Reduction

JavaScript is required to reveal this message. / Email

Back to Top